BCR-ABL 1 RT-qpcr test for improved monitoring of CML
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201500009C
- Awardee
-
Asuragen Incorporated UEI E8M9NXN4X4Y7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,489,494
Award facts
- Opportunity
-
- BAAN44CM4701411 Solicitation number
- Contract value 100% obligated
- $1,489,494.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Austin, TX 78744, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,489,494 |
About this award
This is a federal contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Asuragen Incorporated, a small business. The contract is for the development and supply of a BCR-ABL 1 RT-QPCR test to improve monitoring of chronic myeloid leukemia (CML). This is a Phase II Small Business Innovation Research (SBIR) contract with a ceiling value of $1,489,494.00. The contract is a definitive contract with a cost-plus-fixed-fee pricing type and has a period of performance through December 20, 2017. Asuragen has previously received other federal contract awards and grants from HHS and DoD agencies to supply specialized diagnostic reagents and kits compatible with government medical equipment and testing procedures.
Quick answers
Who was awarded contract HHSN261201500009C?
HHSN261201500009C was awarded to Asuragen Incorporated by National Cancer Institute (National Institutes of Health) on September 21, 2015.
How much is contract HHSN261201500009C worth?
The government has obligated $1,489,494 on HHSN261201500009C.
Was contract HHSN261201500009C competed?
The extent of competition for HHSN261201500009C was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award